← Open Payments lookup

PAUL KUDER: Open Payments

NPI 1801567367 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,955 in 198 payments from 14 companies in 2025. Trend: 2023 $1,763 · 2024 $2,002 · 2025 $2,955

Food & beverage: $2,871Education: $84
CompanyPaymentsAmount
ABBVIE INC.45$719
Takeda Pharmaceuticals U.S.A., Inc.17$362
Madrigal Pharmaceuticals14$258
Salix Pharmaceuticals, a division of Bausch Health US, LLC24$247
Janssen Biotech, Inc.10$192
Ardelyx, Inc.11$191
Ipsen Biopharmaceuticals, Inc18$189
QOL Medical, LLC6$170
Phathom Pharmaceuticals, Inc.19$152
Gilead Sciences, Inc.12$148

Products named: ENTYVIO, REZDIFFRA, XIFAXAN, RINVOQ, TREMFYA, IBSRELA, IQIRVO, Sucraid.

Industry payments across TX — which companies pay providers there.